Últimas noticias sobre FMC (NYSE:FMC) Bolsa

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

FMC Corp

FRMRS&MER BNCORP LODI CA by Farmers & Merchants Bancorp

Farmers & Merchants Bancorp

Federal Home Loan Mortgage Corp

Northern Lights Fund Trust IV FM Compounders Equity ETF

FRESENIUS MED CARE AG ORD by Fresenius Medical Care AG

Fresenius Medical Care AG

FM Focus Equity ETF

FORAN MINING CORP by Foran Mining Corporation

Foran Mining Corp

Citigroup analyst Patrick Cunningham maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and raises the price target from $55 to $61.

News

Price Target

Analyst Ratings

Citigroup Maintains Neutral on FMC, Raises Price Target to $61

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Citigroup analyst Jason Gursky upgraded the rating for Northrop Grumman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) from Neutral to Buy and maintained the price target of $587. Northrop Grumman shares closed at $482.38 on Friday. <a href="https://www.benzinga.com/quote/noc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Benjamin Theurer upgraded FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Equal-Weight to Overweight and maintained the price target of $65. FMC shares closed at $53.43 on Friday. <a href="https://www.benzinga.com/quote/fmc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Durgesh Chopra upgraded the rating for NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) from In-Line to Outperform and raised the price target from $74 to $126. NRG Energy shares closed at $104.51 on Friday. <a href="https://www.benzinga.com/quote/nrg/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Simeon Gutman upgraded Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) from Equal-Weight to Overweight and raised the price target from $430 to $500. Ulta Beauty shares closed at $405.01 on Friday. <a href="https://www.benzinga.com/quote/ulta/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Surinder Thind upgraded the rating for Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) from Hold to Buy and raised the price target from $44 to $55. Genpact shares closed at $45.11 on Friday. <a href="https://www.benzinga.com/quote/G/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ULTA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-1024x572.png" alt="" class="wp-image-742314" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/21072017/image-134.png 1087w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43091705/top-4-health-care-stocks-you-may-want-to-dump-in-q1">Top 4 Health Care Stocks You May Want To Dump In Q1</a></li>
</ul>

Upgrades

Pre-Market Outlook

Markets

Trading Ideas

ULTA

This Ulta Beauty Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Barclays analyst Benjamin Theurer upgrades FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Equal-Weight to Overweight and maintains the price target from $65 to $65.

Barclays Upgrades FMC to Overweight, Maintains Price Target to $65

8 analysts have expressed a variety of opinions on FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $65.5, a high estimate of $81.00, and a low estimate of $55.00. Experiencing a 8.12% decline, the current average is now lower than the previous average price target of $71.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1736877660_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$69.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$66.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$81.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$67.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FMC. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for FMC's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of FMC's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>Unveiling the Story Behind FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: FMC's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 8.5%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.08%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FMC's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.41%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.53%, the company showcases effective utilization of assets.
Debt Management: FMC's debt-to-equity ratio surpasses industry norms, standing at 0.88. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying FMC: Insights From 8 Analyst Reviews

The chemical industry could be in for a turbulent 2025 spurred by increased demand, cost inflation and President-elect <a href="https://www.benzinga.com/markets/commodities/24/11/42235640/trumps-energy-policies-poised-to-reshape-oil-gas-market-winners-and-losers-revealed">Donald Trump&#8216;s PFAS policies</a>.
The Chemicals Analyst: Bank of America analyst Steve Byrne released a note covering the chemicals industry on Tuesday, upgrading and downgrading several companies:
<ul>
<li>Archer-Daniels-Midland Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) from Neutral to Underperform, lowering its price target from $63 to $54.</li>
<li>Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Underperform to Buy, lowering its price target from $95 to $88.</li>
<li>Eastman Chemical Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) from Neutral to Buy, lowering its price target from $115 to $109.</li>
<li>Element Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) from Buy to Neutral, lowering its price target from $32 to $28.</li>
<li>FMC Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Underperform to Neutral, lowering its price target from $63 to $61.</li>
<li>Olin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) from Neutral to Buy, lowering its price target from $48 to $40.</li>
<li>Origin Materials Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGN#NASDAQ">ORGN</a>) from Buy to Underperform, lowering its price target from $2.50 to $1.50.</li>
</ul>
Main Takeaways: Agriculture stocks faced a decline in the waning months of 2024, amid market concerns over potential trade policies under President-elect Trump and the impact of rising interest rates linked to the federal deficit. Byrne believes the market has already re-priced higher risk.
The analyst believes chemicals will see increased demand with a caveat.
&#8220;We expect end-market demand to grow this year, although we&#8217;ve pared back expectations, given incremental headwinds from tariff concerns, a strong USD, and higher interest rate expectations, among others,&#8221; Byrne said. &#8220;Still, the U.S. Manufacturing PMI has been surprisingly weak and the risk-reward is skewed positively in our view.&#8221;
Meanwhile, the analyst foresees a return of inflationary pressures on input costs, squeezing margins.
Byrne says Trump&#8217;s election win and a possible &#8220;trade war&#8221; could slow GDP growth and hurt chemical companies&#8217; bottom lines. He notes deregulation and lower corporate taxes as a positive. The analyst suggests that Trump&#8217;s weakening of the EPA could pause certain regulatory initiatives, potentially increasing litigation risks for PFAS manufacturers.
Company Takeaways: Byrne cited declining profitability and increased macroeconomic risk for his Archer-Daniels-Midland downgrade.
The analyst upgraded Celanese&#8217;s stock based on an expected demand recovery, an attractive valuation and potential benefits from shareholder activism.
Eastman Chemical took a severe hit in 2024&#8217;s fourth quarter. Byrne says the market&#8217;s sell-off was &#8220;overdone&#8221; and is optimistic for future revenue and earnings growth.
Byrne downgraded Element Solutions and said there is better opportunity elsewhere. He noted possible currency headwinds.
FMC could face a tough recovery from its struggles in 2024, but Byrne is optimistic that the company&#8217;s EBITDA can rebound. The analyst says market multiples are &#8220;appropriately reflecting risks.&#8221;
Byrne says Olin&#8217;s valuation is &#8220;highly attractive&#8221; due to its high free cash flow yield. The analyst also said the company is insulated from Trump administration risks.
The analyst&#8217;s downgrade of Origin Materials is linked to doubts that the company will be able to license its technology and possible headwinds for sustainable products.
Price Action: Several of the companies showed sharp movement following the analyst&#8217;s note:
<ul>
<li>Archer-Daniels-Midland traded at $51.18, down 1.8%.</li>
<li>Celanese Corporation traded at $71.97, up 6.81%.</li>
<li>Eastman Chemical traded at $91.77, up 2.99%.</li>
<li>FMC Corp traded at $53.16, up 2.17%.</li>
<li>Olin Corp traded at $33.10, up 4.38%.</li>
<li>Origin Materials traded at $1, down 9.9%.</li>
</ul>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42974739/wall-street-rebounds-as-producer-inflation-misses-estimates-tesla-gains-chinese-stocks-rally">Wall Street Rebounds As Producer Inflation Misses Estimates, Tesla Gains, Chinese Stocks Rally</a></li>
</ul>
Photo: dongfang/Shutterstock.com

Analyst Color

Government

Regulations

Downgrades

Economics

ORGN

Increased Demand, Trump Administration Risks: Analyst Picks Celanese As Chemical Winner, ADM As Loser For 2025

B of A Securities analyst Steve Byrne upgrades FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) from Underperform to Neutral and lowers the price target from $63 to $61.

B of A Securities Upgrades FMC to Neutral, Lowers Price Target to $61

Mizuho analyst Christopher Parkinson maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and lowers the price target from $70 to $55.

Mizuho Maintains Neutral on FMC, Lowers Price Target to $55

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>JMP Securities raised the price target for Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) from $660 to $750. JMP Securities analyst Matthew Condon maintained a Market Outperform rating. Meta shares closed at $585.51 on Tuesday. <a href="https://www.benzinga.com/quote/META/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) price target from $55 to $48. JP Morgan analyst Arun Jayaram maintained an Overweight rating. SLB shares closed at $38.34 on Tuesday. See how other analysts view this stock.</li>
<li>Deutsche Bank cut the price target for Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) from $611 to $523. Deutsche Bank analyst Scott Deuschle downgraded the stock from Buy to Hold. Lockheed Martin shares closed at $485.94 on Tuesday. <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo raised the price target for CyberArk Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) from $350 to $410. Wells Fargo analyst Andrew Nowinski maintained an Overweight rating. CyberArk Software shares closed at $333.15 on Tuesday. See how other analysts view this stock.</li>
<li>Keybanc cut FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) price target from $79 to $69. Keybanc analyst Aleksey Yefremov maintained an Overweight rating. FMC shares settled at $48.61 on Tuesday. <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Northland Capital Markets increased Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) price target from $100 to $120. Northland Capital Markets analyst Gus Richard downgraded the stock from Outperform to Market Perform. Astera Labs shares closed at $132.45 on Tuesday. <a href="https://www.benzinga.com/quote/ALAB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank cut Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) price target from $611 to $523. Deutsche Bank analyst Scott Deuschle downgraded the stock from Buy to Hold. Lockheed Martin shares closed at $485.94 on Tuesday.  <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan slashed the price target for Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) from $55 to $48. JP Morgan analyst Arun Jayaram maintained an Overweight rating. SLB shares settled at $38.34 on Tuesday. <a href="https://www.benzinga.com/quote/SLB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer cut Universal Display Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>) price target from $220 to $200. Oppenheimer analyst Martin Yang maintained an Outperform rating. Universal Display shares closed at $146.20 on Tuesday. <a href="https://www.benzinga.com/quote/OLED/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank increased The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) price target from $184 to $215. Deutsche Bank analyst Scott Deuschle maintained a Buy rating. Boeing shares closed at $177.00 on Tuesday. <a href="https://www.benzinga.com/quote/BA/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42763645/how-to-earn-500-a-month-from-acuity-brands-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Acuity Brands Stock Ahead Of Q1 Earnings</a></li>
</ul>

ALAB

CYBR

OLED

Meta To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and lowers the price target from $79 to $69.

Keybanc Maintains Overweight on FMC, Lowers Price Target to $69

UBS analyst Joshua Spector maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Buy and lowers the price target from $75 to $66.

UBS Maintains Buy on FMC, Lowers Price Target to $66

4 analysts have shared their evaluations of FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated FMC and provided 12-month price targets. The average target is $68.25, accompanied by a high estimate of $81.00 and a low estimate of $55.00. This current average has decreased by 3.42% from the previous average price target of $70.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1734552043_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$81.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$67.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into FMC's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: FMC's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 8.5%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: FMC's net margin is impressive, surpassing industry averages. With a net margin of 6.08%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): FMC's ROE stands out, surpassing industry averages. With an impressive ROE of 1.41%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): FMC's ROA excels beyond industry benchmarks, reaching 0.53%. This signifies efficient management of assets and strong financial health.
Debt Management: FMC's debt-to-equity ratio surpasses industry norms, standing at 0.88. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For FMC

Citigroup analyst Patrick Cunningham maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and lowers the price target from $70 to $55.

Citigroup Maintains Neutral on FMC, Lowers Price Target to $55

Mizuho analyst Christopher Parkinson maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and raises the price target from $64 to $70.

Mizuho Maintains Neutral on FMC, Raises Price Target to $70

RBC Capital analyst Arun Viswanathan maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Outperform and raises the price target from $78 to $81.

RBC Capital Maintains Outperform on FMC, Raises Price Target to $81

WIIM

FMC shares are trading higher after the company reported better-than-expected Q3 financial results.

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.
Shares of Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) gained 13.5% to $12.38 following better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41627569/snap-stock-is-surging-today-whats-going-on">quarterly financial results.</a>
Snap reported third-quarter revenue of $1.373 billion, beating the consensus estimate of $1.358 billion, according to Benzinga Pro. The social media company reported adjusted earnings of 8 cents per share, beating analyst estimates of 5 cents per share.
Snap shares jumped 13.5% to $12.38 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) shares jumped 41.3% to $115.48 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>Omnicell, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) gained 37% to $54.99 after the company reported better-than-expected third-quarter financial results and raised its FY24 guidance above estimates.</li>
<li>Unisys Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UIS#NYSE">UIS</a>) surged 30.7% to $7.03 after the company reported better-than-expected third-quarter sales results and raised its FY24 non-GAAP operating profit margin guidance.</li>
<li>ASP Isotopes Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPI#NASDAQ">ASPI</a>) rose 30.7% to $7.53 after the company announced that it has entered into a term sheet with TerraPower for the construction of a HALEU production facility.</li>
<li>NerdWallet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRDS#NASDAQ">NRDS</a>) gained 27.3% to $14.41 after the company reported better-than-expected quarterly revenue results.</li>
<li>AtriCure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRC#NASDAQ">ATRC</a>) surged 23% to $36.21 after the company reported better-than-expected third-quarter financial results and issued FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $34 to $40.</li>
<li>Garmin Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NASDAQ">GRMN</a>) gained 22.9% to $204.48 after the company reported better-than-expected third-quarter financial results and raised annual outlook.</li>
<li>Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) surged 14.6% to $32.92 after the company reported better-than-expected quarterly financial results and raised its FY24 sales guidance above estimates.</li>
<li>The Cheesecake Factory Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) gained 13.6% to $48.69 after the company reported better-than-expected quarterly adjusted EPS results. Also, multiple firms raised their respective price targets on the stock.</li>
<li>Adtalem Global Education Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NASDAQ">ATGE</a>) rose 12.7% to $84.53 following first-quarter results.</li>
<li>FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) gained 11.5% to $67.12 following better-than-expected quarterly earnings.</li>
<li>OneMain Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) rose 10.8% to $52.63 following strong quarterly earnings.</li>
<li>Smurfit Westrock Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) gained 10.4% to $49.38 following third-quarter results.</li>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) surged 6.2% to $129.21.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) gained 5.3% to $180.25 following better-than-expected third-quarter earnings.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41623120/jim-cramer-says-buy-crowdstrike-stock-calls-this-aerospace-manufacturer-is-a-high-specul">Jim Cramer Says Buy CrowdStrike Stock, Calls This Aerospace Manufacturer A &#8216;High Speculative&#8217; Stock</a></li>
</ul>

Intraday Update

Movers

ASPI

Adtalem Global Education Inc. Common Stock

ATGE

ATRC

CAKE

DELL

EXEL

GOOG

GRMN

NRDS

OMCL

RDDT

SNAP

Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday

Guidance

FMC Sees FY24 Adj. EPS $3.16-$3.52 vs $3.28 Est., Revenue $4.33B-$4.44B vs $4.364B Est.

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.53 by 30.19 percent. The company reported quarterly sales of $1.070 billion which beat the analyst consensus estimate of $1.036 billion by 3.32 percent. This is a 8.97 percent increase over sales of $981.900 million the same period last year.

Earnings

Earnings Beats

FMC Q3 2024 Adj. EPS $0.69 Beats $0.53 Estimate, Sales $1.070B Beat $1.036B Estimate

Ratings for FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $67.0, along with a high estimate of $79.00 and a low estimate of $59.00. This upward trend is evident, with the current average reflecting a 5.93% increase from the previous average price target of $63.25.
<img src="https://www.benzinga.com/files/images/story/2024/1729702841_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$67.00</td>
<td>-</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$59.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$81.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into FMC's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FMC analyst ratings.</a>
<h2>Get to Know FMC Better</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>Financial Milestones: FMC's Journey</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining FMC's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 2.36% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: FMC's net margin excels beyond industry benchmarks, reaching 28.33%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): FMC's ROE stands out, surpassing industry averages. With an impressive ROE of 6.63%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): FMC's ROA stands out, surpassing industry averages. With an impressive ROA of 2.44%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: FMC's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.92, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Key Takeaways From FMC Analyst Ratings

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B. Riley Securities analyst Hal Goetsch initiated coverage on Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Neutral rating and announced a price target of $185. Coinbase shares closed at $210.72 on Tuesday. <a href="https://www.benzinga.com/quote/COIN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>CLSA initiated coverage on Charles River Laboratories International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) with an Underperform rating and announced a price target of $167. Charles River shares closed at $185.94 on Tuesday. <a href="https://www.benzinga.com/quote/CRL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Patrick Cunningham initiated coverage on FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral rating and announced a price target of $67. FMC shares closed at $62.38 on Tuesday. <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Daiwa Capital initiates coverage on Grab Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) with an Outperform rating and announced a price target of $4.6. Grab shares closed at $4.16 on Tuesday. <a href="https://www.benzinga.com/quote/GRAB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer initiated coverage on Ferguson Enterprises Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) with an Outperform rating and announced a price target of $234. Ferguson shares closed at $195.99 on Tuesday. <a href="https://www.benzinga.com/quote/FERG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read More:<a href="https://www.benzinga.com/news/earnings/24/10/41479244/dow-edges-lower-as-investors-watch-earnings-reports-with-caution-fear-index-remains-in-greed-zone"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41479244/dow-edges-lower-as-investors-watch-earnings-reports-with-caution-fear-index-remains-in-greed-zone">Dow Edges Lower As Investors Watch Earnings Reports With Caution: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Initiation

COIN

FERG

GRAB

This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

The S&P 500's 10 worst-performing stocks in 2023 fell again in 2024

Mizuho lowered the firm's price target on FMC (FMC) to $55 from $70 and keeps a Neutral rating on the shares. In conjunction with its 2025 outlook ...

FMC price target lowered to $55 from $70 at Mizuho

Wells Fargo's Harvey: Investors could be driving pricing strategy in stocks

BofA upgraded FMC (FMC) to Neutral from Underperform with a price target of $61, down from $63. Published first on TheFly – the ultimate source for...

FMC upgraded to Neutral from Underperform at BofA

As previously reported, BofA analyst Steve Byrne upgraded FMC (FMC) to Neutral from Underperform with a price target of $61, down from $63. While t...

FMC upgraded to Neutral at BofA with growth headwinds priced in

Eastman Chemical, Olin, Celanese, FMC upgraded at Bank of America

Bets against S&P 500 materials stocks jump in December, International Paper most shorted

Barclays upgraded FMC (FMC) to Overweight from Equal Weight with an unchanged price target of $65. Entering 2025, the firm is more optimistic about...

FMC upgraded to Overweight from Equal Weight at Barclays

Citi analyst Patrick Cunningham, CFA maintained a Hold rating on FMC (FMC – Research Report) today and set a price target of $61.00. The company's ...

Citi Remains a Hold on FMC (FMC)

Citi raised the firm's price target on FMC (FMC) to $61 from $55 and keeps a Neutral rating on the shares. The firm reduced Q4 earnings estimates a...

FMC price target raised to $61 from $55 at Citi

ALLE

AMCR

CTVA

ENPH

ETSY

MDLZ

MRNA

PAYC

UPRO

Commodities

Press Releases

FMC Corporation announces dates for third quarter 2024 earnings release and webcast conference call

FMC Corporation and UN Global Compact Network USA convene global leaders to discuss future of sustainable food systems during United Nations General Assembly

Contracts

FMC Corporation announces distribution agreement with Ballagro Agro Tecnologia Ltda. to expand biologicals crop protection offering in Brazil

FMC Corporation reports strong growth in third quarter, confirms full-year outlook adjusted for expected sale of GSS business

FMC Corporation and Envu complete the sale of FMC's Global Specialty Solutions business

FMC Corporation announces election of Anthony DiSilvestro to Board of Directors

Dividends

FMC Corporation Declares Quarterly Dividend

FMC Corporation announces date for fourth quarter 2024 earnings release and webcast conference call

FMC Corporation announces date of 2025 annual meeting of stockholders

Legal

FMC ALERT: Bragar Eagel & Squire, P.C. is Investigating FMC Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

Comments

FMC

Noticias

Últimas noticias sobre FMC (NYSE:FMC) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL